TWiV 880: COVID-19 clinical update #107 with Dr. Daniel Griffin
This Week in Virology
00:00
Antiplatelet Therapy for Covid 19 a Ranimas Control Trial
The early inflammatory change, right? This is where folks might get sick enough to end up in hospital. A study the effect of antiplatetherapy on survival and organ free days and critically ill patients with covid 19 a ranimas control trial was just published in jama m. It suggested, based on this data, there was a low likelihood that these would provide benefit. So still recommending a hepron primarily low molecular hepon not e data to suggest a benefit for anti platelet agents such as asprin.
Transcript
Play full episode
